MUSHLIH, Y.; SURYOADJI, K. A.; PRASETYAWATY, F. Survival Rate of Gemcitabine Monotherapy after Prior Platinum-based Chemotherapy for Metastatic Bladder Cancer. Cermin Dunia Kedokteran, [S. l.], v. 49, n. 12, p. 693–701, 2022. DOI: 10.55175/cdk.v49i12.329. Disponível em: https://cdkjournal.com/index.php/cdk/article/view/329. Acesso em: 30 oct. 2024.